Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Parry

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Bioscience : a Journal and Virtual Library|June 16, 2007
Hepsin and prostate cancerQingyu Wu, Gordon Parry
Plos One|February 2, 2011
Detection of hepatocyte growth factor (HGF) ligand-c-MET receptor activation in formalin-fixed paraffin embedded specimens by a novel proximity assayRajiv Dua, Jianhuan Zhang, Gordon Parry, et al.
Breast Cancer Research and Treatment|October 28, 2009
EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistanceRajiv Dua, Jianhuan Zhang, Phets Nhonthachit, et al.
Breast Cancer Research : BCR|April 19, 2011
Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of actionLisa DeFazio-Eli, Kristi Strommen, Trang Dao-Pick, et al.
Plos One|February 8, 2011
Profiling the HER3/PI3K pathway in breast tumors using proximity-directed assays identifies correlations between protein complexes and phosphoproteinsAli Mukherjee, Youssouf Badal, Xuan-Thao Nguyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2009
In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude miceDouglas W Schneider, Tara Heitner, Bruno Alicke, et al.
Cancer Research|April 5, 2005
Targeting tomoregulin for radioimmunotherapy of prostate cancerXiao-Yan Zhao, Doug Schneider, Sandra L Biroc, et al.
Cancer Research|April 6, 2006
Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in cultureJian-Ai Xuan, Doug Schneider, Pam Toy, et al.
Molecular Cancer Therapeutics|January 9, 2003
Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cellsPaul H Johnson, Roger P Walker, Steven W Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2010
Quantitation of p95HER2 in paraffin sections by using a p95-specific antibody and correlation with outcome in a cohort of trastuzumab-treated breast cancer patientsJeff Sperinde, Xueguang Jin, Jayee Banerjee, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Bioscience : a Journal and Virtual Library|June 16, 2007
Hepsin and prostate cancerQingyu Wu, Gordon Parry
Plos One|February 2, 2011
Detection of hepatocyte growth factor (HGF) ligand-c-MET receptor activation in formalin-fixed paraffin embedded specimens by a novel proximity assayRajiv Dua, Jianhuan Zhang, Gordon Parry, et al.
Breast Cancer Research and Treatment|October 28, 2009
EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistanceRajiv Dua, Jianhuan Zhang, Phets Nhonthachit, et al.
Breast Cancer Research : BCR|April 19, 2011
Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of actionLisa DeFazio-Eli, Kristi Strommen, Trang Dao-Pick, et al.
Plos One|February 8, 2011
Profiling the HER3/PI3K pathway in breast tumors using proximity-directed assays identifies correlations between protein complexes and phosphoproteinsAli Mukherjee, Youssouf Badal, Xuan-Thao Nguyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2009
In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude miceDouglas W Schneider, Tara Heitner, Bruno Alicke, et al.
Cancer Research|April 5, 2005
Targeting tomoregulin for radioimmunotherapy of prostate cancerXiao-Yan Zhao, Doug Schneider, Sandra L Biroc, et al.
Cancer Research|April 6, 2006
Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in cultureJian-Ai Xuan, Doug Schneider, Pam Toy, et al.
Molecular Cancer Therapeutics|January 9, 2003
Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cellsPaul H Johnson, Roger P Walker, Steven W Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2010
Quantitation of p95HER2 in paraffin sections by using a p95-specific antibody and correlation with outcome in a cohort of trastuzumab-treated breast cancer patientsJeff Sperinde, Xueguang Jin, Jayee Banerjee, et al.
Pageof 2